Baye Galligan is an analyst at Lumira Ventures, Canada’s most active healthcare-focused venture capital firm. She focuses on business and technical due diligence and analyses of investment opportunities, as well as financial analysis and proactive industry research.
Prior to joining Lumira, Baye was Research Manager at the National Angel Capital Organization and Associate Director of Maple Leaf Angels, the largest network of angel investors in Toronto, where she evaluated applications for early-stage investment, conducted due diligence, and organized community building initiatives. Baye holds a M.A. in organic chemistry from Harvard University, where she was an executive member of the Harvard Women in Chemistry. She also holds an HBA from the Richard Ivey School of Business and a B.Sc. in chemistry from Western University.